Nano-theranostics: A novel platform in drug therapy

Sailaja Gunnam *, Sharat Chandrika Sandru, Monika Nijhawan and Rajeswari Aleti

Department of Pharmaceutics, Gokaraju Rangaraju College of Pharmacy, Affiliated to Osmania University, Bachupally, Nizampet, Hyderabad -500090, India.
 
Review Article
World Journal of Advanced Research and Reviews, 2024, 23(03), 1706–1716
Article DOI10.30574/wjarr.2024.23.3.2799
 
Publication history: 
Received on 03 August 2024; revised on 12 September 2024; accepted on 14 September 2024
 
Abstract: 
A fundamental component of customized medicine, theranostics is a therapy approach that combines therapeutics and diagnostics with the goal of increasing drug efficacy and safety while also monitoring treatment response. It will require significant advancements in predictive medicine. Theranostics is linked to tailored drug administration based on test results as well as a diagnostic that screens patients for potential adverse drug reactions. Early diagnosis and treatment have benefited from the designed nanoparticles with unique physicochemical characteristics. This allows treatments to be delivered and the detection method to be employed concurrently, not just before or after treatment but throughout the entire regimen. The development of nanotechnology presents more opportunities for theranostics applications using nanoparticle engineering, and it has demonstrated encouraging outcomes, particularly in cancer therapy when compared with conventional treatments.
 
Keywords: 
Customized Medicine; Theranostics; Nanoparticles; Diagnostic Imaging; Tailored Drug; Cancer therapy
 
Full text article in PDF: 
Share this